☆BAKER BROS. ADVISORS LP
Quality Q
0.959
AUM ($M)
19,955
Positions
84
Turnover
0.12
Top-10 wt
73%
Herfindahl
0.076
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 92 positions · portfolio value $19,955M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆INCY funds › | Incyte Corporation | ADD | — | 17.5% | +0.9% | 3,487.2 | 30,762,330 | +17,918 | 5 | — |
| ☆ONC funds › | BeOne Medicines Ltd. | ADD | — | 12.6% | -2.4% | 2,508.2 | 8,801,567 | +2,514 | 5 | — |
| ☆RVMD funds › | Revolution Medicines, Inc. | ADD | — | 10.7% | +5.4% | 2,143.1 | 11,443,357 | +1,888,000 | 5 | — |
| ☆MDGL funds › | Madrigal Pharmaceuticals, Inc. | ADD | — | 5.8% | -0.7% | 1,150.8 | 2,143,131 | +1,430 | 5 | — |
| ☆ACAD funds › | ACADIA Pharmaceuticals Inc. | ADD | — | 5.4% | -0.0% | 1,085.7 | 42,912,904 | +16,214 | 5 | — |
| ☆KYMR funds › | Kymera Therapeutics, Inc. | HOLD | — | 5.0% | +0.8% | 992.7 | 8,657,242 | +0 | 5 | — |
| ☆INSM funds › | Insmed Incorporated | ADD | — | 4.7% | -2.3% | 937.8 | 8,796,111 | +1,375,000 | 5 | — |
| ☆CELC funds › | Celcuity Inc. | HOLD | — | 4.2% | -1.0% | 828.2 | 7,915,792 | +0 | 5 | — |
| ☆KOD funds › | Kodiak Sciences Inc. | HOLD | — | 3.9% | -0.5% | 776.1 | 19,919,186 | +0 | 5 | — |
| ☆RYTM funds › | Rhythm Pharmaceuticals, Inc. | HOLD | — | 3.1% | +0.3% | 622.3 | 5,604,483 | +0 | 5 | — |
| ☆PRAX funds › | Praxis Precision Medicines, Inc. | HOLD | — | 2.9% | -0.3% | 587.0 | 1,753,198 | +0 | 5 | — |
| ☆ALKS funds › | Alkermes plc | HOLD | — | 2.6% | +0.6% | 524.6 | 10,012,267 | +0 | 5 | — |
| ☆SMMT funds › | Summit Therapeutics Inc. | TRIM | — | 2.4% | -1.6% | 477.7 | 32,786,348 | -3,604,715 | 5 | — |
| ☆GRAL funds › | GRAIL, Inc. | HOLD | — | 1.4% | +0.2% | 275.0 | 4,028,614 | +0 | 5 | — |
| ☆ABCL funds › | AbCellera Biologics Inc. | ADD | — | 1.3% | +0.7% | 259.1 | 33,012,138 | +2,736,200 | 5 | — |
| ☆IMVT funds › | Immunovant, Inc. | TRIM | — | 1.0% | +0.3% | 209.4 | 5,435,220 | -22,661 | 5 | — |
| ☆IDYA funds › | IDEAYA Biosciences, Inc. | ADD | — | 0.9% | +0.2% | 186.7 | 5,010,030 | +1,063,515 | 5 | — |
| ☆KNSA funds › | Kiniksa Pharmaceuticals International, plc | ADD | — | 0.9% | +0.1% | 181.3 | 2,834,643 | +8,397 | 5 | — |
| ☆CUSIP:G76279101 funds › | Roivant Sciences Ltd. | TRIM | — | 0.8% | +0.1% | 166.9 | 4,716,831 | -150,892 | 5 | — |
| ☆ARWR funds › | Arrowhead Pharmaceuticals, Inc. | HOLD | — | 0.8% | +0.1% | 162.4 | 1,992,783 | +0 | 5 | — |
| ☆IONS funds › | Ionis Pharmaceuticals, Inc. | HOLD | — | 0.8% | -0.1% | 162.4 | 2,047,727 | +0 | 4 | — |
| ☆EWTX funds › | Edgewise Therapeutics, Inc. | TRIM | — | 0.8% | -0.4% | 150.4 | 3,701,719 | -2,874,221 | 5 | — |
| ☆REPL funds › | Replimune Group, Inc. | HOLD | — | 0.6% | +0.1% | 122.3 | 11,045,336 | +0 | 5 | — |
| ☆NRIX funds › | Nurix Therapeutics, Inc. | HOLD | — | 0.6% | +0.2% | 113.0 | 4,658,556 | +0 | 5 | — |
| ☆STOK funds › | Stoke Therapeutics, Inc. | HOLD | — | 0.5% | -0.1% | 109.2 | 3,336,697 | +0 | 5 | — |
| ☆GLUE funds › | Monte Rosa Therapeutics, Inc. | HOLD | — | 0.5% | +0.1% | 105.2 | 4,345,736 | +0 | 5 | — |
| ☆IMTX funds › | Immatics N.V. | TRIM | — | 0.5% | -0.1% | 96.3 | 9,508,565 | -1,408,128 | 5 | — |
| ☆DNLI funds › | Denali Therapeutics Inc. | ADD | — | 0.5% | +0.1% | 96.0 | 3,734,336 | +2,641 | 5 | — |
| ☆CRNX funds › | Crinetics Pharmaceuticals, Inc. | HOLD | — | 0.4% | -0.0% | 88.0 | 2,351,465 | +0 | 5 | — |
| ☆DNTH funds › | Dianthus Therapeutics, Inc. | HOLD | — | 0.4% | +0.0% | 83.1 | 852,164 | +0 | 5 | — |
| ☆GPCR funds › | Structure Therapeutics Inc. | HOLD | — | 0.4% | -0.0% | 76.9 | 1,432,529 | +0 | 5 | — |
| ☆CUSIP:15102KAA8 funds › | Celcuity Inc. | HOLD | — | 0.3% | -0.1% | 69.2 | 30,750,000 | +0 | 4 | — |
| ☆RAPP funds › | Rapport Therapeutics, Inc. | HOLD | — | 0.3% | +0.0% | 64.5 | 1,547,090 | +0 | 5 | — |
| ☆ALMS funds › | Alumis Inc. | HOLD | — | 0.3% | +0.0% | 56.6 | 2,012,500 | +0 | 5 | — |
| ☆PRLD funds › | Prelude Therapeutics Inc. | HOLD | — | 0.3% | +0.1% | 54.0 | 10,123,824 | +0 | 5 | — |
| ☆RLAY funds › | Relay Therapeutics, Inc. | ADD | — | 0.3% | +0.2% | 52.9 | 2,826,783 | +1,666,666 | 5 | — |
| ☆MIRM funds › | Mirum Pharmaceuticals, Inc. | HOLD | — | 0.3% | +0.0% | 52.2 | 445,975 | +0 | 2 | — |
| ☆BCYC funds › | Bicycle Therapeutics plc | HOLD | — | 0.2% | -0.1% | 46.2 | 10,885,357 | +0 | 5 | — |
| ☆ELVN funds › | Enliven Therapeutics, Inc. | HOLD | — | 0.2% | +0.0% | 45.9 | 905,191 | +0 | 5 | — |
| ☆CLDX funds › | Celldex Therapeutics, Inc. | ADD | — | 0.2% | +0.1% | 44.0 | 1,182,611 | +517,241 | 5 | — |
| ☆VRDN funds › | Viridian Therapeutics, Inc. | ADD | — | 0.2% | -0.0% | 43.8 | 2,383,025 | +411,347 | 5 | — |
| ☆DSGN funds › | Design Therapeutics, Inc. | ADD | — | 0.2% | +0.0% | 38.8 | 2,678,430 | +92,452 | 5 | — |
| ☆TRDA funds › | Entrada Therapeutics, Inc. | HOLD | — | 0.2% | -0.2% | 37.3 | 5,072,730 | +0 | 5 | — |
| ☆FTH funds › | Faeth Therapeutics, Inc. | NEW | — | 0.2% | +0.2% | 32.2 | 1,286,411 | +1,286,411 | 1 | — |
| ☆AKTS funds › | Aktis Oncology, Inc. | HOLD | — | 0.2% | +0.1% | 32.1 | 996,351 | +0 | 2 | — |
| ☆NGNE funds › | Neurogene Inc. | HOLD | — | 0.2% | +0.0% | 31.2 | 991,691 | +0 | 5 | — |
| ☆JBIO funds › | Jade Biosciences, Inc. | TRIM | — | 0.1% | +0.0% | 27.3 | 1,230,426 | -410,711 | 3 | — |
| ☆TSHA funds › | Taysha Gene Therapies, Inc. | HOLD | — | 0.1% | +0.0% | 27.3 | 4,004,756 | +0 | 5 | — |
| ☆RCUS funds › | Arcus Biosciences, Inc. | ADD | — | 0.1% | +0.1% | 26.0 | 844,816 | +429,195 | 3 | — |
| ☆IRON funds › | Disc Medicine, Inc. | HOLD | — | 0.1% | -0.0% | 25.6 | 349,657 | +0 | 5 | — |
| ☆ABSI funds › | Absci Corporation | HOLD | Common Stock | 0.1% | +0.1% | 24.7 | 2,134,803 | +0 | 3 | — |
| ☆GENB funds › | Generate Biomedicines, Inc. | HOLD | — | 0.1% | +0.0% | 24.0 | 1,423,602 | +0 | 2 | — |
| ☆DBVT funds › | DBV Technologies S.A. | HOLD | — | 0.1% | -0.1% | 24.0 | 1,461,425 | +0 | 5 | — |
| ☆XENE funds › | Xenon Pharmaceuticals Inc. | HOLD | — | 0.1% | -0.0% | 22.3 | 370,208 | +0 | 5 | — |
| ☆TECX funds › | Tectonic Therapeutic, Inc. | HOLD | — | 0.1% | -0.0% | 20.9 | 607,788 | +0 | 5 | — |
| ☆CERS funds › | Cerus Corporation | TRIM | — | 0.1% | -0.0% | 18.7 | 6,395,431 | -3,612,914 | 5 | — |
| ☆CTMX funds › | CytomX Therapeutics, Inc. | HOLD | — | 0.1% | -0.0% | 18.7 | 4,975,826 | +0 | 5 | — |
| ☆DYN funds › | Dyne Therapeutics, Inc. | HOLD | — | 0.1% | +0.0% | 18.1 | 813,449 | +0 | 3 | — |
| ☆CYTK funds › | Cytokinetics, Incorporated | NEW | — | 0.1% | +0.1% | 18.0 | 211,267 | +211,267 | 1 | — |
| ☆XNCR funds › | Xencor, Inc. | HOLD | — | 0.1% | +0.0% | 17.7 | 1,102,106 | +0 | 5 | — |
| ☆SION funds › | Sionna Therapeutics, Inc. | HOLD | — | 0.1% | -0.0% | 17.6 | 400,000 | +0 | 5 | — |
| ☆NTLA funds › | Intellia Therapeutics, Inc. | NEW | — | 0.1% | +0.1% | 15.7 | 930,232 | +930,232 | 1 | — |
| ☆PBLS funds › | Parabilis Medicines, Inc. | NEW | — | 0.1% | +0.1% | 13.7 | 500,000 | +500,000 | 1 | — |
| ☆MPLT funds › | MapLight Therapeutics, Inc. | HOLD | — | 0.1% | +0.0% | 13.1 | 364,705 | +0 | 3 | — |
| ☆AVLN funds › | Avalyn Pharma Inc. | NEW | — | 0.1% | +0.1% | 11.5 | 350,000 | +350,000 | 1 | — |
| ☆EVMN funds › | Evommune, Inc. | HOLD | — | 0.1% | -0.1% | 11.3 | 847,390 | +0 | 2 | — |
| ☆BNTX funds › | BioNTech SE | HOLD | — | 0.1% | -0.0% | 11.1 | 119,743 | +0 | 5 | — |
| ☆TNGX funds › | Tango Therapeutics, Inc. | NEW | — | 0.1% | +0.1% | 10.4 | 333,333 | +333,333 | 1 | — |
| ☆AVTX funds › | Avalo Therapeutics, Inc. | NEW | — | 0.1% | +0.1% | 10.2 | 550,000 | +550,000 | 1 | — |
| ☆SERA funds › | Sera Prognostics, Inc. | HOLD | — | 0.1% | -0.0% | 10.0 | 5,498,170 | +0 | 5 | — |
| ☆VSTM funds › | Verastem, Inc. | ADD | — | 0.0% | +0.0% | 9.5 | 2,499,338 | +1,914,581 | 2 | — |
| ☆SGMT funds › | Sagimet Biosciences Inc. | HOLD | — | 0.0% | +0.0% | 7.4 | 952,996 | +0 | 5 | — |
| ☆EIKN funds › | Eikon Therapeutics, Inc. | HOLD | — | 0.0% | +0.0% | 7.2 | 555,555 | +0 | 2 | — |
| ☆LBRX funds › | LB Pharmaceuticals Inc. | HOLD | — | 0.0% | +0.0% | 6.5 | 200,000 | +0 | 4 | — |
| ☆VTVT funds › | vTv Therapeutics, Inc. | HOLD | — | 0.0% | -0.0% | 5.6 | 148,314 | +0 | 5 | — |
| ☆WVE funds › | Wave Life Sciences Ltd. | HOLD | — | 0.0% | -0.0% | 4.8 | 822,638 | +0 | 5 | — |
| ☆TARA funds › | Protara Therapeutics, Inc. | HOLD | — | 0.0% | -0.0% | 3.7 | 971,614 | +0 | 5 | — |
| ☆TCRX funds › | TScan Therapeutics, Inc. | HOLD | — | 0.0% | -0.0% | 2.7 | 2,784,792 | +0 | 5 | — |
| ☆IMNM funds › | Immunome, Inc. | NEW | — | 0.0% | +0.0% | 1.2 | 55,306 | +55,306 | 1 | — |
| ☆SKYE funds › | Skye Bioscience, Inc. | HOLD | — | 0.0% | -0.0% | 1.1 | 1,575,243 | +0 | 5 | — |
| ☆SANA funds › | Sana Biotechnology, Inc. | HOLD | — | 0.0% | +0.0% | 1.1 | 310,483 | +0 | 5 | — |
| ☆ALGS funds › | Aligos Therapeutics, Inc. | HOLD | — | 0.0% | -0.0% | 0.5 | 83,055 | +0 | 5 | — |
| ☆TYRA funds › | Tyra Biosciences, Inc. | HOLD | — | 0.0% | -0.0% | 0.3 | 10,607 | +0 | 5 | — |
| ☆CUSIP:86889P117 funds › | Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) | HOLD | — | 0.0% | -0.0% | 0.0 | 833,333 | +0 | 5 | — |
| ☆CTNM funds › | Contineum Therapeutics, Inc. | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -1,420,838 | 0 | — |
| ☆ARGX funds › | argenx SE | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -25,174 | 0 | — |
| ☆PHVS funds › | Pharvaris N.V. | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -375,000 | 0 | — |
| ☆CMPS funds › | COMPASS Pathways plc | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -2,344,720 | 0 | — |
| ☆ABVX funds › | Abivax S.A. | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -875,796 | 0 | — |
| ☆CUSIP:152309100 funds › | Centessa Pharmaceuticals plc | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -670,751 | 0 | — |
| ☆SYRE funds › | Spyre Therapeutics, Inc. | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -1,000,000 | 0 | — |
| ☆IMCR funds › | Immunocore Holdings plc | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -734,397 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 19,955 | 84 | 0.12 | 73% | 0.076 | 0.958 | — | in |
| 2026Q1 | 17,416 | 84 | 0.07 | 73% | 0.076 | 0.971 | — | in |
| 2025Q4 | 17,079 | 86 | 0.13 | 74% | 0.081 | 0.946 | — | in |
| 2025Q3 | 13,839 | 91 | 0.10 | 79% | 0.105 | 0.960 | — | in |
| 2025Q2 | 10,308 | 89 | 0.12 | 82% | 0.110 | 0.956 | — | entered |
| 2025Q1 | 9,037 | 89 | 0.00 | 82% | 0.133 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status